Belite Bio, Inc
BLTE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,927 | $1,217 | $602 | $255 |
| - Cash | $32 | $88 | $42 | $17 |
| + Debt | $1 | $1 | $1 | $32 |
| Enterprise Value | $1,896 | $1,129 | $561 | $270 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$36 | -$31 | -$12 | -$10 |
| % Margin | – | – | – | – |
| Net Income | -$36 | -$32 | -$13 | -$10 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.18 | -1.19 | -0.63 | -0.4 |
| % Growth | 0.8% | -88.9% | -57.5% | – |
| Operating Cash Flow | -$29 | -$30 | -$11 | -$7 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$29 | -$30 | -$12 | -$8 |